Pittenger & Anderson’s VanEck Pharmaceutical ETF PPH Stock Holding History
Bought
Maintained
Sold
Other funds holding PPH
Pittenger & Anderson's PPH Position: Q3 2026 in Review
Pittenger & Anderson opened a new position in VanEck Pharmaceutical ETF (PPH) in Q3 2026: 5,685 shares worth $622K. The stake represents 0.02% of the portfolio and ranks #194 among its holdings.
156 funds tracked by Wall St. Rank hold PPH as of Q3 2026.
- Pittenger & Anderson held 5,685 shares of VanEck Pharmaceutical ETF worth $622K as of Q3 2026.
- VanEck Pharmaceutical ETF was a new Pittenger & Anderson position in Q3 2026.
- VanEck Pharmaceutical ETF made up 0.02% of Pittenger & Anderson's portfolio in Q3 2026, its #194 holding.
- 156 funds tracked by Wall St. Rank held VanEck Pharmaceutical ETF as of Q3 2026.
Based on Pittenger & Anderson's 13F filing for Q3 2026, filed 2 Nov 2026.